Blincyto savings in Tijuana, Mexico

Patients researching Blincyto cost are often looking for ways to better manage out-of-pocket expenses. ProviderX helps eligible patients coordinate access to Blincyto (blinatumomab) through licensed pharmacies in Tijuana, Mexico, using a structured cross-border prescription program.

Based on recent cross-border quotes, many patients report meaningful Blincyto cost savings compared to typical U.S. cash pharmacy prices. Savings vary depending on prescription details, availability, and pharmacy partner.

Savings are estimates only. Final costs depend on prescription details, pharmacy, and availability. ProviderX does not prescribe medications, operate a pharmacy, or ship medications into the United States.

*Example medication packaging from licensed providers in Tijuana.

How to get this medication

Blincyto is a specialty prescription medication, which often requires additional coordination compared to standard prescriptions. Below is a clear, step-by-step overview of how access is coordinated through ProviderX.

How to get Blincyto

Send Us Your Prescription Securely

Upload your valid U.S. prescription for Blincyto through our HIPAA-secure form. We only work with prescriptions issued by licensed U.S. healthcare providers

Once eligibility is confirmed, our team coordinates the logistics required for your visit to Tijuana and prepares the medication pickup with licensed pharmacy partners.

You will visit licensed pharmacies in Tijuana where Blincyto is prepared and made available in accordance with international regulatory standards.

Pick up your medication in person and return home the same day, with guidance and coordination support throughout the process.

About Blincyto

What Blincyto is
Blincyto (blinatumomab) is a prescription medication classified as a bispecific T-cell engager (BiTE) antibody construct. It is manufactured by Amgen and is available only with a valid prescription.

Approved medical uses (factual)
According to official prescribing information, Blincyto is approved for use in patients with B-cell precursor acute lymphoblastic leukemia (ALL), including:

  • Relapsed or refractory B-cell precursor ALL, and

  • Minimal residual disease (MRD)-positive B-cell precursor ALL in patients who meet labeled criteria.

Important medical notice
This information is provided for educational purposes only. ProviderX does not provide medical care, prescribe medications, or offer treatment recommendations. Decisions regarding Blincyto should be made by a licensed healthcare provider familiar with the patient’s medical history.

Learn more about medications and cross-border savings

Related conditions

Fermentum tincidunt laoreet donec

Fermentum tincidunt laoreet donec

Other medicament

Yervoy
Enbrel
Copaxone
Stivarga
Rituxan (Ruxience)

Browse Conditions by Letter

Nisl adipiscing leo id magna egestas eget dapibus enim et. Massa non scelerisque porttitor.

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

R

S

T

V

X